MASCC/ISOO Clinical Practice Guidelines for Management of Mucositis Included in the National Guideline Clearinghouse

2014    The MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy are now included in the National Guideline Clearinghouse™ (NGC). The NGC is a database of evidence-based clinical practice guidelines and related documents, maintained as a public resource by the US Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services. Inclusion in the NGC is contingent on meeting rigorous criteria, including evidence of a systematic literature review, systematically developed recommendations for optimal care in specific clinical circumstances, and an assessment of the benefits and harms of recommended care. The NGC carries the latest update of MASCC Mucositis Guidelines, published by Rajesh Lalla et al in Cancer in May, 2014 (open access).

These Guidelines represent a major accomplishment of the Mucositis Study Group. The preparation included a comprehensive, systematic review of the literature related to mucositis and the development of evidence-based clinical practice guidelines. The reviews included literature on mucositis interventions, pathogenesis, and the risk of oral and gastrointestinal mucosal injury associated with targeted cancer therapies.

Share this post: